PP
Peter Parriathcherry Jose Ansal
About Peter Parriathcherry Jose Ansal
Data last updated:
Peter Parriathcherry Jose Ansal has 22 years in corporate governance. Holds Director role. Currently with 3 companies, including Rhine Biogenics Private Limited and Rhine Life Sciences Private Limited. Engaged in General Business. Contributes to corporate operations. The 3 current companies with reported revenue have a combined latest revenue of ₹58.35 Cr; the largest is Rhine Biogenics Private Limited at ₹53.20 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Rhine Biogenics Private Limited U24232KL2003PTC016519 | Director | 17 Nov 2003 | 2003 | ₹53.20 Cr (FY 2025) | Active |
 Rhine Life Sciences Private Limited U24232KL2006PTC019505 | Director | 08 Jun 2006 | 2006 | ₹5.14 Cr (FY 2025) | Active |
| Moselle Drugs And Cosmetics Limited U24290HR2019PLC077772 | Director | 10 Jan 2019 | 2019 | ₹27,804 (FY 2024) | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Peter Parriathcherry Jose Ansal
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Peter Parriathcherry Jose Ansal
Peter Parriathcherry Jose Ansal has 22 years in corporate governance. Holds Director role. Currently with 3 companies, including Rhine Biogenics Private Limited and Rhine Life Sciences Private Limited. Engaged in General Business. Contributes to corporate operations. The 3 current companies with reported revenue have a combined latest revenue of ₹58.35 Cr; the largest is Rhine Biogenics Private Limited at ₹53.20 Cr (FY 2025).
Peter Parriathcherry Jose Ansal is associated with 3 companies as Director, including Rhine Biogenics Private Limited (₹53.20 Cr), Rhine Life Sciences Private Limited (₹5.14 Cr), Moselle Drugs And Cosmetics Limited (₹27,804).
Peter Parriathcherry Jose Ansal has expertise in General Business.
Peter Parriathcherry Jose Ansal has 22 years in corporate governance.
By reported revenue, the largest current company of Peter Parriathcherry Jose Ansal is Rhine Biogenics Private Limited, with revenue of ₹53.20 Cr (FY 2025).
The 3 current companies of Peter Parriathcherry Jose Ansal that report revenue have a combined latest revenue of ₹58.35 Cr.
Peter Parriathcherry Jose Ansal currently holds positions at 3 companies: Rhine Biogenics Private Limited (₹53.20 Cr), Rhine Life Sciences Private Limited (₹5.14 Cr), Moselle Drugs And Cosmetics Limited (₹27,804).